RankAlpha logo
Back to Rankings

ANTX

AN2 TherapeuticsC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
ANTX vs peer average
70/100
ANTX vs. peer average (C vs. D)
Grade spread
B 1 · C 2 · D 1 · F 7
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

MRKR is the first available peer comparator.

Clinical-stage micro-cap biotech with event-driven trading and funding sensitivity; useful for comparing how ANTX may respond to milestone slippage versus cash support.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerMRKRMarker Therapeutics
ANTX
AN2 Therapeutics
MRKR
Marker Therapeutics
Grade
C
B
Momentum
83
74
Value
41
41
Sentiment
34
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs MRKR

ANTX / MRKR
Grade Position
Above peers
ANTX vs. peer average (C vs. D)
70/100
Momentum
83
ANTX
Value
41
ANTX
Sentiment
34
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ANTX
1
MRKR
MRKR
B
80/100
-1
2
SNTI
SNTI
F
20/100
+2
3
BRNS
BRNS
F
20/100
+2
4
HUMA
Humacyte Inc Common
F
20/100
+2
5
TNYA
Tenaya Therapeutics Inc Common
C
60/100
Even
MRKR is the first peer returned for this comparison set.